K. Ono et al., MIDDLE DOSE-RATE IRRADIATION IN COMBINATION WITH CARBOGEN INHALATION SELECTIVELY AND MORE MARKEDLY INCREASES THE RESPONSES OF SCCVII TUMORS, International journal of radiation oncology, biology, physics, 29(1), 1994, pp. 81-85
Citations number
26
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Carbogen increases the radiation response of tumors and reduc
ed dose rate irradiation spares the damage of normal tissues. The purp
ose in this paper is to investigate the possibility of selective radio
sensitization of tumors by reduced dose rate irradiation in combinatio
n with carbogen inhalation. Methods and Materials: SCCVII tumors in C3
H/He mice were irradiated at middle dose rate (0.1 Gy/min) or high dos
e rate irradiation (3.0 Gy/min) in combination with carbogen inhalatio
n. The mice were enclosed in a box with carbogen flushing at 1.0 l/min
. The tumor response was measured by a cytokinesis block micronucleus
assay. The effects on intestinal crypt cells and bone marrow cells wer
e investigated by microcolony assay or Hendry's method, respectively.
Results: The anti-tumor effect of middle dose rate irradiation was equ
al to that of a high dose rate irradiation. Carbogen inhalation, more
efficiently, increased the antitumor effect when combined with middle
and high dose rate irradiation, and yielded enhancement ratios of 1.6
at around 2 Gy. Middle dose rate irradiation produced less damage on i
ntestinal crypt cells and bone marrow cells in comparison with high do
se rate irradiation, and carbogen inhalation never enhanced the respon
ses of these normal tissues in combination with middle dose rate irrad
iation. Dose modifying factors were 1.3-2.0. Conclusion: Since middle
dose rate irradiation in combination with carbogen inhalation gave the
therapeutic gain factors of 2.0-3.2, which were much larger than thos
e obtained with any other radiosensitizers, this combination has a pot
ential as a new modality for improving the results of cancer radiother
apy.